News

Ex-Lionsgate exec plans venture firm focused on massive gaming biz

Fundraising cools at end of summer for emerging managers

Coefficient, F2 and Cultivation lead the way in last two weeks in August.

Benelux amasses more than $988 mln in VC investments in 2019

Friday Letter: Construction is the new VC darling; NEA 17 marches along; and a VC in a unicorn shirt

A weekly letter from the VCJ editor about an assortment of what's happening in VC, along with who we're meeting and what we're hearing

Pear Ventures eyes new digs in historic Menlo Park building

Structure Capital's next fund to focus on growth investing

ePACT becomes first Canadian woman-led deal of Elaine Kunda’s Disruption Ventures

Canadian venture activity soars in robust H1

LACERS bets $35 mln on NEA’s latest mega-fund

NEA 17 has now raised capital from at least nine public pensions, including Nebraska, Sacramento and LA pension funds.

VC-backed Pionyr names Levey as SVP and chief business officer

Pionyr Immunotherapeutics Inc, a developer of antibody therapeutics, has appointed Dr. Alicia Levey as senior vice president and chief business officer. Previously, Levey worked at Tempest Therapeutics where she was vice president and chief business officer. Pionyr's backers included OrbiMed, New Enterprise Associates, Sofinnova, SV Health Investors, Vida Ventures, Trinitas Capital, Mission Bay Capital and Osage University Partners.